Transforming growth factor-beta and Smad signalling in kidney diseases.
about
Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signalingDipeptidyl peptidase-4 and kidney fibrosis in diabetesPathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic FibrosisIschemia reperfusion control: the key of kidney graft outcomeSmads as therapeutic targets for chronic kidney diseaseRegulation of autophagy by TGF-β: emerging role in kidney fibrosisEarly Cellular Changes in the Ascending Aorta and Myocardium in a Swine Model of Metabolic SyndromeRole of the TGF-β/BMP-7/Smad pathways in renal diseasesCurcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cellsOmega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidneyResponse gene to complement 32 is essential for fibroblast activation in renal fibrosisTreatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis.PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells.Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model.Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice.Kidney dysfunction in patients with pulmonary arterial hypertensionStromal fibroblast activation and their potential association with uterine fibroids (Review).Mesenteric resistance arteries in type 2 diabetic db/db mice undergo outward remodeling.Smad3 knock-out mice as a useful model to study intestinal fibrogenesisResveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3miR-192 mediates TGF-beta/Smad3-driven renal fibrosis.Augmenter of liver regeneration ameliorates renal fibrosis in rats with obstructive nephropathy.Effects of dietary salt restriction on puromycin aminonucleoside nephrosis: preliminary data.Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition.Exacerbation of diabetic renal alterations in mice lacking vasohibin-1.Vasohibin-1 deficiency enhances renal fibrosis and inflammation after unilateral ureteral obstructionSmad2 protects against TGF-beta/Smad3-mediated renal fibrosis.Absence of chloride intracellular channel 4 (CLIC4) predisposes to acute kidney injury but has minimal impact on recoveryThe effects of the water-extraction of Astragali Radix and Lycopi herba on the Pathway of TGF-smads-UPP in a rat model of Diabetic Nephropathy.Suramin inhibits renal fibrosis in chronic kidney disease.Induced autologous stem cell transplantation for treatment of rabbit renal interstitial fibrosisTherapeutic targets for treating fibrotic kidney diseasesChaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.IHG-1 promotes mitochondrial biogenesis by stabilizing PGC-1α.Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signalingAlphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy.AMP-activated protein kinase (AMPK) activation inhibits nuclear translocation of Smad4 in mesangial cells and diabetic kidneys.Identification of ALK5 inhibitor via structure-based virtual screening and ADMET prediction.
P2860
Q24313188-20CD4E25-2384-46BC-9F6F-B7E9520A8B60Q26766089-10A96466-F1D6-4B5C-89F4-CE94AC31A77FQ26771232-1A18BC89-FA2A-4F81-8E51-7D980A9B2C27Q26858856-FD9CDC35-89BC-4FC5-92FD-7AA9E783CC59Q26865998-EB435449-EBB4-4AB6-B9B1-33452F384174Q27023146-6A6D307F-2F9A-410E-A8B5-34F253F8658AQ27332290-3C67B7BD-8C83-40A3-B78B-4A4E1A1A5C58Q28278757-044C485B-A274-455F-BADE-641707F73B95Q28489058-00F1D606-37DE-4F9A-951E-4C86CBF8959BQ28570995-54E3CFDD-C951-43ED-AC53-FBF2449831ECQ28588339-F0BCE2E7-35AE-46AF-ABFC-7B627C2868A3Q30484142-3F546071-8EC4-44F0-A828-016D361071DBQ33552194-754AD933-5D4D-4385-B59E-4159CFA7308CQ33593163-1874C623-9872-4E9F-B988-AB34C64F31E4Q33620712-1417A063-76BC-4475-AB7B-F75B293D47B3Q33738621-0215E11C-CB26-45EF-827B-5FE0EFB56F0CQ33844177-6B74C11B-863D-4061-9512-21BB8D9D8EFBQ33988848-6706698B-5E82-4682-94B5-E3B432308F19Q34013157-F4CC6C5A-82A0-4DF3-80BE-EE3C8F78DD7FQ34086829-AA118797-EAD7-41A4-B019-D62F81C1411AQ34124178-A78AE98F-2253-4680-877D-0FC566007194Q34139895-3453E5B3-F326-47F4-BAAA-877A20D8FE73Q34206000-EFAAC535-B78D-411E-A016-05E42B868F9FQ34221944-87087F6B-5877-4EBE-B80F-5CEFC031475FQ34257934-15D54126-EE21-4D0A-B52C-CE24358EA192Q34399941-082E80C0-A113-45AC-BB3F-4A3C9B905E4CQ34455322-D31051E6-B467-4E4C-B390-EF1AA1722474Q34523816-93D7C955-8BE3-4412-B1A8-BAA9F643F258Q34553251-DE7F3AC7-B694-408A-867E-4896B26CC272Q35012404-C764DD7F-B623-4BA9-8CEE-D9EAB1D3F67AQ35075572-37A76720-651B-4567-9B6B-7C764E4BED14Q35079607-A231534B-16B8-4787-98DB-D91EDE8D6115Q35124896-CB94EB2E-4F2A-4954-9A8D-C6319F9A83CEQ35142716-1851494F-5F2B-4BE1-9D85-11B7BCA0FAA3Q35188138-E4431FF1-8C1B-4B46-BEAA-91B4C8F40DEEQ35230894-D9876A42-816B-4613-8B83-6708D674A802Q35570438-20428360-61B6-4ABC-AD32-E51090E61B03Q35607297-E090BD26-662B-4762-AA1A-93B40D3CE0DEQ35622481-05C80B65-C17D-4AA1-9D73-DFDAA6212486Q35652477-FAE78B7D-4681-4150-9AA1-C98D13B6DB45
P2860
Transforming growth factor-beta and Smad signalling in kidney diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Transforming growth factor-beta and Smad signalling in kidney diseases.
@ast
Transforming growth factor-beta and Smad signalling in kidney diseases.
@en
type
label
Transforming growth factor-beta and Smad signalling in kidney diseases.
@ast
Transforming growth factor-beta and Smad signalling in kidney diseases.
@en
prefLabel
Transforming growth factor-beta and Smad signalling in kidney diseases.
@ast
Transforming growth factor-beta and Smad signalling in kidney diseases.
@en
P1433
P1476
Transforming growth factor-beta and Smad signalling in kidney diseases
@en
P2093
Vijay Koka
Wansheng Wang
P356
10.1111/J.1440-1797.2005.00334.X
P50
P577
2005-02-01T00:00:00Z